){kind=logo}
"I tell people it's a life changer and I am a changed man!" - UK Inspire therapy user.
An estimated 8 million people in the UK are suffering with OSA (obstructive sleep apnoea). Since 2014 more than 100,000 patients worldwide including a growing number of British OSA sufferers in the last few years have pursued restful sleep with Inspire therapy. This well studied and established therapy (over 350 publications) demonstrates significant AHI (Apnoea-Hypopnea Index) and quality of life improvements.
Reimbursed by the NHS, access for more patients in England is increasing regularly. Supported by a wealth of evidence across Europe & USA through real-world registries and 350+ clinical articles, data from thousands of patients continues to prove Inspire to be safe and effective, with results sustained in the long-term.
With 90% patient satisfaction and high therapy adherence, Inspire is designed with patients' needs at the core, silently and discreetly treating the root cause of OSA by working inside the body in synchronisation with the patient’s natural breathing.
Address
Inspire Medical Systems GMBHInspire Medical Systems Europe GmbH
Neuer Wall 80
Hamburg
Germany
20354
Germany
Contact Exhibitor
News
-
)
Inspire Medical Systems Europe GmbH, a medical technology company focused on the development of innovative, minimally invasive solutions for obstructive sleep apnoea, today announced eight major NHS h ...
Products
-
)
Through hypoglossal nerve stimulation, Inspire therapy provides a safe and effective alternative for moderate to severe OSA patients who cannot tolerate using CPAP. Over 100,000 patients worldwide hav ...
